12 Recruiting Non-small Cell Lung Cancer (NSCLC) Phase 1 Clinical Trials
Active phase 1 studies for non-small cell lung cancer (nsclc) enrolling across the USA. Verify eligibility and contact site coordinators.
All Non-small Cell Lung Cancer (NSCLC) studiesPhase 1 Studies for Non-small Cell Lung Cancer (NSCLC)
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
📍 UCLA — Santa Monica, California
View Study & Checklist ➔U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
📍 City of Hope — Duarte, California
View Study & Checklist ➔Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
📍 Henry Ford Health — Detroit, Michigan
View Study & Checklist ➔Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
📍 ArriVent Investigative Site — Prescott, Arizona
View Study & Checklist ➔Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
📍 Highlands Oncology Group — Springdale, Arkansas
View Study & Checklist ➔Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
📍 Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center — Fullerton, California
View Study & Checklist ➔Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
📍 UC Irvine/Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
📍 University of California, Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
📍 Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium) — Nashville, Tennessee
View Study & Checklist ➔